Biogen Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $4.59B | $3.97B | $616.1M | $154.8M |
| FY2017 | $4.55B | $3.68B | $867.4M | $128.0M |
| FY2018 | $6.19B | $5.42B | $770.6M | $157.5M |
| FY2019 | $7.08B | $6.56B | $514.5M | $182.3M |
| FY2020 | $4.23B | $3.81B | $424.8M | $198.3M |
| FY2021 | $3.64B | $3.38B | $258.1M | $238.6M |
| FY2022 | $1.38B | $1.14B | $240.3M | $254.1M |
| FY2023 | $1.55B | $1.27B | $277.0M | $264.2M |
| FY2024 | $2.88B | $2.72B | $153.7M | $291.2M |
| FY2025 | $2.20B | $2.05B | $153.8M | $290.8M |